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The opportunism of Pseudomonas aeruginosa (PA) in immunocompromised hosts prompted us to
explore the potential role of sialic acids (Sia) in this phenomenon. Culture of PA in the presence
of exogenous Sia resulted in linkage-specific incorporation of Sia which was associated with
decreased complement deposition on the bacteria. Sia acquired by PA mediated enhanced binding
of bacteria to recombinant-CHO cells expressing human siglec-7 or siglec-9, as well as to human
NK-cells and monocytes naturally expressing these siglecs. Therefore, Sia may be acquired by PA
in the host and contribute to bacterial pathogenicity and host-cell interactions via reduction of com-
plement deposition and siglec-dependent recognition.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Pseudomonas aeruginosa (PA) is a Gram-negative opportunistic
bacterium, which often infects immunocompromised hosts [1].
The establishment of successful bacterial infection requires protec-
tion from the host’s plasma components and the association with
host cells through appropriate receptor–ligand interactions. Lipo-
polysaccharides and capsular antigens of Gram-negative bacteria
play important roles in maintaining structural integrity and deter-
mining the host responses via pattern recognition receptors [2].
We recently identified a sialoglycosylated periplasmic ABC-type
phosphate transporter of PA from peripheral blood mononuclear
cells (PBMC) of patients with visceral leishmaniasis (PBMCVL) [3].
A number of microbial pathogens are able to either synthesize or
acquire Sia from the environment as a form of molecular mimicry
(Supplementary Fig. S1, [2]). Acquired sialic acid (Sia) is likely to be
important in pathogenicity, e.g. via Factor H-dependent inhibition
of complement C3-deposition [4]. Recent findings have also shownchemical Societies. Published by E
73 5197.
t authors.that Sia binding immunoglobulin-like lectins (siglecs) expressed on
various immune cells can promote cellular recognition of sialylated
bacteria [5–7].
The presence of Sia on PA and its potential role in interactions
with host receptors has not been studied previously. Here, we re-
port the linkage-specific Sia on PA, possibly adsorbed from culture
medium. Sia uptake by PA was positively correlated with the pre-
vention of C3-deposition. Furthermore we demonstrate that PA-
associated Sia specifically engage siglecs on host immune cells.
To the best of our knowledge, this is the first report of Sia being
a potentially important constituent of PA, possibly influencing
the persistence and association within the immunosuppressed
host via siglecs and other host molecules.
2. Methods
2.1. Detection of Sia on PA
PA, a wild-type, prototrophic, virulent burn wound isolate were
grown on Trypticase soy broth (TSB, DIBCO) or on agar plates in a
microaerobic atmosphere and harvested after 16 h of growth.
Bacteria live or heat-killed (60 C for 1 h) were washed withlsevier B.V. All rights reserved.
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the spectrophotometric method and confirmed by pour plate col-
ony counts to get colony forming units (CFU).
PA (live and heat-killed) was labeled with FITC, suspended in
assay buffer (20 mM HEPES, 150 mM NaCl, 1% BSA, pH 7.4) and
enumerated using a bacterial cytometer, a fluorescent microscope
and by flow cytometry (BD-FACS Calibur) [6].
Sia liberated from bacteria (1  1015 CFU) was purified and sep-
arated on a TLC plate [8]. Purified Sia from bovine submandibular
mucin (BSM) and authentic Neu5Ac served as standards.
PA (9.3  109 CFU) grown in only TSB medium, their washes
and membrane fractions or PA (1  109 CFU) grown with Neu5Ac
(0–120 min) were oxidized separately to quantify Sia by fluorimet-
ric acetyl acetone method [9]. Relative fluorescence intensity [exci-
tation410 nm/emission510 nm] of the fluorogen was measured with
an F-4010 spectrofluorimeter (Hitachi).
1,2-Diamino-4,5-methylenedioxybenzene (DMB)-derivatized
purified Sia (0.02 ml) from PA (before and after saponification),
equal volumes of fresh and spent TSB media were analyzed by fluo-
rimetric reverse-phase HPLC [3,8]. Each fraction (2–20 pmol/ll)
was analyzed by MALDI-TOF-MS (Applied Biosystem) and by ESI-
MS on a Q-TOF micromass spectrometer (Waters Corporation) [3].
2.2. Detection of linkage-specific Sia
Membrane fractions were prepared from washed PA
(2.5  108 CFU) and analyzed by DIG-glycan and differentiation
kits (Roche Applied Science) using Galanthus nivalis agglutinin
(GNA), Sambucus nigra agglutinin (SNA), Maackia amurensis aggluti-
nin (MAA), Peanut agglutinin (PNA) and Datura stramonium aggluti-
nin (DSA) as per manufacturer’s protocol [3,8].
Membrane fractions were coated and incubated with biotinyla-
ted (B)-SNA and B-MAA overnight at 4 C and detected using
horseradish peroxidase (HRP)-avidin and read on an ELISA-plate
reader. The occurrence of Sia on PA (2.5  106 CFU/ml) in the ab-
sence and presence of exogenous Neu5Ac (0–120 min) was ana-
lyzed separately using B-SNA and B-MAA by flow cytometry.
The status of O-acetylation of Sia was analyzed by flow cytom-
etry by incubating PA with FITC-Achatinin-H (0–1 lg) [3]. To con-
firm the specificity, PA was de-sialylated and de-O-acetylated with
Arthrobacter ureafaciens sialidase and 9-O-acetyl haemagglutinin
esterase separately. The binding of Achatinin-H with PA was also
determined using anti-Achatinin-H antibodies by ELISA [3].
In overlay dot blotting, sialylated and de-sialylated PA were air-
dried separately onto nitrocellulose membrane (2.5  106 CFU/
dot), blocked in PBS-3%BSA and overlaid with several soluble hu-
man siglec-Fc chimeras [10]. The blots were washed, incubated
with B-anti-human Fc for 1 h at 25 C and the bound siglec-Fc com-
plexes were detected using HRP-avidin and quantified by densito-
metric analysis using Master Totallab Software, version 1.11.
In a spectrofluorimetric ELISA, protein A (0.5 lg/ll) was coated
overnight and incubated with soluble human siglec-7-Fc and sig-
lec-9-Fc chimeras (0.5 lg/ll, 100 ll) [6]. The wells were washed,
FITC-PA (2.5  106 CFU/well) was allowed to adhere for 10 min at
37 C [6], washed and the residual fluorescence intensity was mea-
sured using a CytoFlourII fluorescent plate reader.
2.3. Complement deposition assay
Freshly prepared normal human serum (NHS) was incubated
with PA (1  109 CFU) for 30 min on ice [11], centrifuged and the
clear supernatant was designated as adsorbed NHS (Ads-NHS).
Both NHS and Ads-NHS were used at 1:40 dilution as sources of
complement.
C3-deposition was measured using FITC-anti-human C3a-chain
MAbs (SIM27-49) [11]. PA (1  107 CFU) cultured in absence andpresence of exogenous Neu5Ac (1 mM) for 0–120 min, washed
and immediately incubated separately without or with 40% NHS,
Ads-NHS and heat-inactivated serum (HI-NHS) in assay buffer con-
taining CaCl2 (5 mM), MgCl2 (2.5 mM), at 37 C for 3 min. The reac-
tion was terminated using ice-cold PBS-BSA containing 5.0 mM
EDTA, washed, incubated with FITC-anti-C3 (1:50) in PBS–BSA for
30 min at 4 C, and C3-deposition was determined by flow cytom-
etry. C3-deposition was compared with sialidase-(10 mU/
106 CFU)-treated PA. Additionally, the classical pathway (CP) was
blocked using EGTA (10 mM) and MgCl2 (10 mM) and processed.
After termination of complement reaction both untreated and
sialidase-treated PA in TSB and TSB containing Sia were washed,
diluted and appropriate dilutions were plated on TSB-agar for bac-
tericidal assay. Bacterial counts were presented as CFU.
2.4. Association of PA to host cells by adhesion assay
PBMCVL and cells from normal donors (PBMCN) was separated
by Ficoll-Paque. Chinese hamster ovary (CHO) cell transfectants
expressing full-length forms of human siglec-7 (CHO-siglec-7)
and siglec-9(CHO-siglec-9) were grown to 80% confluence with
HAM’s F12 medium containing 10% fetal calf serum, standard anti-
biotics; lifted using PBS and EDTA (2 mM) along with control wild-
type CHO(WT-CHO) cells [12].
Washed CHO-siglec-7 and CHO-siglec-9 were incubated for 1 h
at 4 C with FITC-PA (10 bacteria/cell). Binding assays using de-
sialylated CHO-siglec cells and FITC-PA along with de-sialylated
FITC-PA and de-sialylated CHO-siglec cells were performed. PA
(sialylated and de-sialylated) with WT-CHO cells and pre-blocked
CHO-siglec-7 and CHO-siglec-9 with anti-siglec-7 (7.7A) and
anti-siglec-9 (kalli) MAbs [13,14] were performed similarly. In par-
allel, binding of FITC-PA with PBMCN and PBMCVL was performed.
Side- and forward-scatter properties were used to distinguish
cells from free bacteria [7]. Results were expressed as a bacterial
binding index, calculated by multiplying the FITC-positive cells
(%) with the mean fluorescence intensity (MFI). Phycoerythrin
(PE)-anti-CD3, PE-anti-CD19, PE-anti-CD56, PE-anti-CD14 for T-,
B-, NK-cells and monocytes of the lymphocyte gate in PBMC popu-
lation were checked for FITC-PA positivity and MFI was calculated.
2.5. Statistical analysis
Values show the means ± S.D. of triplicate results from single
representative experiments. Three independent experiments were
carried out for each assay. Student’s t-test was used to determine
the level of statistical significance.3. Results
3.1. Presence of Sia
TLC analysis of bacterial hydrolysates demonstrated the pres-
ence of Neu5Ac, its glycolyl derivative (Neu5Gc) and 9-O-AcSia
(Neu5,9Ac2) in PA (Fig. 1a). Their presence was also confirmed by
fluorimetric-HPLC, which exhibited three intense peaks in the
chromatogram, as compared to those derived from BSM (Fig. 1b).
A marked reduction of the peak coinciding with Neu5,9Ac2 after al-
kali treatment indicated its sensitivity to saponification. MALDI-
TOF-MS of free DMB-Sia showed the presence of the molecular ions
corresponding to all three Sia (Fig. 1c).
Comparable amounts of Sia were observed on unwashed bacte-
ria (6.7 ± 0.45 lg), extensively washed bacteria (5.5 ± 0.32 lg) and
the membrane fraction (5.46 ± 0.22 lg) of PA by fluorimetric quan-
titation. To exclude Sia, which were weakly associated with the
bacterial surface, PA was washed four times (50 ml/wash) with
Fig. 1. Identification of Sia on PA by TLC (a), fluorimetric-HPLC (b) and MALDI-TOF-MS (c). Purified Sia from BSM and commercially available Neu5Ac served as standards.
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ties of Sia (0.21 ± 0.03–0.11 ± 0.02 lg), indicating their strong
attachment.
HPLC fractions corresponding to Neu5Ac demonstrated the
characteristic molecular ion (m/z 426, [M+H]+), its sodium adduct
(m/z 448, [M+Na]+) and a characteristic second group ion at m/z
408, [M+H-18]+ by ESI-MS. The spectra of Neu5Gc displayed char-
acteristic ions m/z at 424, 442, 464 corresponding to [M+H-18]+,
[M+H]+, [M+Na]+, respectively. Similarly, the spectra of Neu5,9Ac2
demonstrated m/z at 450, 468, 490 corresponding to [M+H-18]+,
[M+H]+, [M+Na]+, respectively.
Additionally, each fraction corresponding to Neu5Ac, Neu5Gc
and Neu5,9Ac2, yielded the expected signal for the sodium cation-
ized molecular ion having m/z at 448.7, 464.8 and 490.6, convinc-
ingly demonstrating their presence on PA by MALDI-TOF MS.
3.2. Presence of linkage-specific 9-O-AcSia
B-SNA and B-MAA specific for the a2,6- and a2,3-linkages
exhibited similar dose-dependant binding with both live and
heat-killed bacteria, the densitometric scores being 48 555 ±
1102 and 43 355 ± 1042 (P < 0.001) (Fig. 2b and c). This lectin
binding was lost following sialidase-treatment, the values being
31.13 ± 1.24% to 1.21 ± 0.54% and 30.00 ± 3.26–1.31 ± 0.18%,
respectively, as detected by flow cytometry. The binding of PA to
the GNA, DSA, and PNA specific for Man, Gal and GlcNAc was much
lower.
Densitometric analysis revealed a higher PA-binding with sig-
lec-7-Fc (2436 ± 301) compared to siglec-3-Fc (985 ± 225)
(Fig. 2d). The binding was negligible with desialylated PA confirm-
ing siglec-specific recognition through Sia.Although a panel of immobilized soluble siglec-Fc chimeras
exhibited complex binding with PA, maximal and minimal binding
was observed with siglec-7-Fc (44.20 ± 2.51) and siglec-3-Fc
(13.89 ± 2.01), respectively, by spectrofluorimetric ELISA. A marked
reduction in the binding of siglec-7-Fc (3.07 ± 1.51) and siglec-3-Fc
(3.91 ± 1.81) with desialylated PA provided additional evidence of
the presence of Sia on the bacterial surface.
The presence of the Neu5,9Ac2a2-6GalNAc sialoglycotope was
confirmed through the dose-dependent binding of Achatinin-H
with PA (the OD405 nm being 1.12 ± 0.35, Fig. 2c). De-O-acetyla-
tion caused a significant reduction of Achatinin-H+PA from
35.52 ± 1.12% to 0.82 ± 0.04%, as detected by flow cytometry. A
comparable amount of 9-O-AcSia as a percentage of total Sia was
detected on intact bacteria (26.37 ± 1.12%) and the membrane frac-
tion (21.42 ± 1.05%) (Fig. 2e).
3.3. PA acquire Sia from the culture medium
Fresh TSB medium revealed the presence of Neu5Ac and
Neu5Gc (Fig. 3a), which was confirmed by MALDI-TOF-MS
(Fig. 3b). TSB medium contained 5.13 lg/ml of Neu5Ac, whereas
spent medium had reduced levels (4.0 lg/ml) based on fluori-
metric estimation. These observations, suggest that TSB provides
a source of Sia for the PA surface-associated Sia.
PA (1  109 CFU) cultured for 120 min in TSB medium displayed
only 0.60 ± 0.08 lg of Sia, whereas in the presence of exogenously
added Neu5Ac under identical conditions considerably higher lev-
els of Sia were observed (2.75 ± 0.17 lg). A linear increase in bind-
ing with B-SNA was observed when PA was cultured in TSB
medium containing exogenously added Neu5Ac (0–120 min), indi-
cating enhanced uptake of Sia (Fig. 4a).
Fig. 2. Linkage-specific Sia on PA. (a and b) Densitometric scoring of glycosylation and sialylation profiles of membrane (h) by (a) DIG-glycan detection kit as compared to
controls (j) and (b) differentiation kits. (c) ELISA. The binding of PA-membrane before (h) and after (j) enzyme treatment with SNA, MAA and Achatinin-H. * indicates
P < 0.005 for the binding of SNA and MAA with sialidase-treated versus untreated-bacteria, and ** indicates P < 0.001 for the binding of Achatinin-H with esterase-treated
versus untreated-bacteria. (d) Overlay dot blotting. The binding of sialylated (j) and desialylated (h) PA to soluble human siglec-Fc chimeras. * Indicates P < 0.001 for the
binding of sialidase-treated versus untreated bacteria. (e) The 9-O-AcSia (%) on PA was determined by fluorimetric quantitation.
Fig. 3. PA acquire Sia from the culture medium as detected by fluorimetric-HPLC (a) and MALDI-TOF-MS (b).
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Fig. 4. C3-deposition and Sia-siglec recognition. (a) Increased Sia on PA leads to decreased C3-deposition. Sia-positive bacteria* (%SNA+ cells) and acquired Sia was
quantitated ** fluorimetrically. The CFU of neuraminidase, *** untreated and **** treated PA was detected by bactericidal assay. (b) FITC-PA binds with CHO-siglec-7,-9.
Binding of untreated (PASia+) or neuraminidase-treated (PASia), (bold-line) is compared with only CHO-cells (thin-line). Binding of PASia+ with (a) CHO-siglecs compared to
PASia; (b) preincubated CHO-siglecs with the respective anti-siglec-7,-9 antibodies; (c) unmasked CHO-siglecs by sialidase; and (d) preincubated sialidase-treated CHO-
siglecs with the respective anti-siglecs antibodies.
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In the absence of exogenous Neu5Ac (0 h culture), PA
exhibited the highest C3-deposition, with 74.06 ± 3.22% binding
with the anti-C3 Mab (Fig. 4a), and yielded 2.5 ± 0.25 
104 CFU. C3-deposition showed a gradual decrease with an
increasing exposure time of PA to exogenous Neu5Ac. The bind-
ing of PA with anti-C3 after 120 min of exposure was only
12.32 ± 2.75% and had 8.45 ± 0.31  105 CFU, suggesting thatthe acquired Sia prevented C3-deposition and as a result resis-
tance to bacterial lysis.
In contrast, sialidase-treated PA, showed significantly increased
C3-deposition in the absence (82.65 ± 2.75%) and presence
(75.23 ± 1.97%) of exogenous Neu5Ac and decreased CFU of
3.3 ± 0.17  103 and 2.9 ± 0.24  103, respectively suggesting the
significance of the absorbed Sia in C3-deposition. Ads-NHS showed
a similar trend and the absence of C3-deposition with HI-NHS
reconfirmed the role of SA.
Fig. 5. Sia-dependent recognition of NK-cells and monocytes by PA. The MFI associated with the specific cells gated for FITC-PA fluorescence.
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3.5.1. CHO-siglec cells
The potent binding of PA with recombinant soluble siglec-7
(Fig. 3d) inspired us to investigate whether cells expressing siglecs
could interact directly with PA. The binding of FITC-PA with CHO-
siglec-7 was considerably higher than the control CHO cells, indi-
cating a siglec-dependent association (Fig. 4b). Desialylation of
CHO-siglec-7,-9 to unmask siglecs from cis-interactions [10] con-
sistently resulted in increased overall binding of PA (Fig. 4b). The
Sia dependence of bacterial binding was confirmed by a consider-
able reduction in the binding of desialylated FITC-PA with CHO-sig-
lec-7,-9. In addition, binding was almost abrogated after pre-
blocking the cells with anti-siglec-7 and anti-siglec-9 antibodies,
indicating siglec-specific recognition.
3.5.2. PBMCN and PBMCVL
Human siglec-9 is present on monocytes whereas siglec-7 is ex-
pressed strongly on natural killer (NK) cells [5]. In flow cytometry-
based binding assays, monocytes(CD14+) of PBMCVL evidenced a
4.3-fold reduced binding to sialidase-treated FITC-PA as compared
to only 2.5-fold reduction observed with monocytes of PBMCN
(Fig. 5). Thus PA showed sialidase-sensitive binding to both
NK(CD56+) cells and monocytes. The PA-binding of T(CD3+)- and
B(CD19+)-lymphocyte population of PBMCVL was not reduced fol-
lowing sialidase-treatment representing Sia-independent binding.
The binding of FITC-PA with NK-cells and monocytes of PBMCN
was lower than the immune cells of VL, suggesting enhanced
cell-specific recognition in the immune-suppressed host.
4. Discussion
The present study conclusively establishes the presence of Sia
on cultured PA and provides evidence for their time-dependant
acquisition from the medium containing exogenously addedNeu5Ac. Most significantly, PA-Sia is a potentially important deter-
minant of the protection against complement deposition and may
play a role in association with the host cells via siglecs.
Glycosylation in PA has been reported in the form of an O-linked
glycan in pilin, identical to the lipopolysaccharide O-antigen of this
bacterium [15]. A cluster of seven pel genes encoding proteins with
similarity to the components involved in the polysaccharide bio-
genesis is found in PA [16]. In general, the regulation of sialylation
depends on the balance between sialyltransferase, sialidase, O-ace-
tyltransferase and esterase [8]. Bioinformatic searches through the
genome of PA indicated the absence of defined sialylation machin-
ery, raising the possibility that the medium could be an alternative
source for PA-Sia. Interestingly, PA cultured with exogenous
Neu5Ac demonstrated enhanced time-dependant acquisition of
Sia. However, whether Sia are transferred wholly or partially re-
mains an area of future research.
Pathogens often protect themselves from the activity of plasma
complement-mediated lysis and microbial sialylation has been
shown to inhibit complement activation [4,17]. Interestingly, PA
cultured for 120 min in non-supplemented TSB medium exhibited
a 6-fold higher anti-C3 binding compared to PA cultured in the
presence of exogenously added Neu5Ac. This provided evidence
for a direct correlation between the Sia levels and the hindrance
of C3-deposition on PA, suggesting a way of escaping the plasma
defense mechanism.
Another possible way that sialylated pathogens protect them-
selves from immune responses is to engage inhibitory siglecs ex-
pressed on various cells of the innate immune system [5–7].
Most siglecs are masked by cis-interactions with Sia present on
the same cells but they can be unmasked by desialylation [10].
Here, strong binding to PA-Sia was observed with siglec-7 and -9,
both as recombinant proteins and expressed on transfected CHO
cells. Selective Sia-dependent binding of PA-Sia to PBMC was ob-
served with sialidase-treated NK-cells and monocytes. As these
cells express unmasked forms of siglec-7,-9, respectively [5] they
B. Khatua et al. / FEBS Letters 584 (2010) 555–561 561may play a role in promoting bacterial interactions during natural
infections in vivo.
Although PA stimulates a complex inflammatory response, the
specific contributions of different mediators in the host-defense
against this bacterium have yet to be fully characterized. As far
as the VL-host is concerned, their associations with immunosup-
pression provide a convenient gateway for the bacteria. We
propose that the Sia of PA contributes to the inhibition of C3-depo-
sition, thus helping them to persist within the host. Acquisition of
Sia may also promote association with the immune cells through
siglec-dependent recognition. As many siglecs have features of
inhibitory receptors [5], this could lead to immunosuppression
and hence contribute to bacterial virulence.
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